GT BIOPHARMA, INC.
Income Statement
| Line Item | FY2011 | FY2010 |
|---|---|---|
| Revenue | $26.0K | $11.0K |
| Cost of Revenue | $48.0K | $65.0K |
| Gross Profit | $-22.0K | $-54.0K |
| Gross Margin | -84.6% | -490.9% |
| Operating Expenses | ||
| Research & Development | $17.0K | $179.0K |
| SG&A Expense | $3.5M | $2.3M |
| Operating Income | $-3.9M | $-2.5M |
| Operating Margin | -15,107.7% | -22,700.0% |
| Interest Expense | $556.0K | $513.0K |
| Pretax Income | $-3.7M | $-3.0M |
| Income Tax Expense | $0 | — |
| Net Income | $-3.7M | $-3.0M |
| Net Margin | -14,230.8% | -27,227.3% |
| EPS (Basic) | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 3.25T | 1.80T |
| Shares Outstanding (Diluted) | 3.25T | 1.80T |
| Dividends Per Share | — | — |